• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估膀胱癌变异组织学行膀胱切除术时间的影响。

Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer.

机构信息

USC Institute of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA.

USC Institute of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA.

出版信息

Urology. 2019 Nov;133:157-163. doi: 10.1016/j.urology.2019.07.034. Epub 2019 Aug 14.

DOI:10.1016/j.urology.2019.07.034
PMID:31421144
Abstract

OBJECTIVE

To determine if the timing of radical cystectomy for variant histology of urothelial carcinoma has an impact on survival. Variant histology has been associated with aberrant behavior compared to pure urothelial carcinoma, however the timing of surgery for these patients has not been studied.

MATERIALS AND METHODS

We identified 363 patients with cT2-T4N0M0 urothelial carcinoma who underwent radical cystectomy without perioperative intravesical and/or systemic therapy from 2003 to 2014. Clinicopathologic data were compared between pure urothelial carcinoma and variant histology. The time from diagnosis to radical cystectomy was analyzed as a continuous variable and dichotomized at 4-, 8-, and 12-weeks to determine impact on oncologic outcomes.

RESULTS

Patients with variant histology, when compared to those with pure urothelial carcinoma, were more likely to present with extravesical disease (P <.01), be upstaged (P <.01), have lymphovascular invasion (P <.01) and have lymph node metastasis at radical cystectomy (P = .02). The median days to radical cystectomy did not differ between pure urothelial and variant histology. On multivariable analysis controlling for age, comorbidities, tumor stage, lymph node status, lymphovascular invasion, and surgical margins, every month in delay was associated with a worse overall survival for variants (HR = 1.36, P = .003). At an 8-week delay or longer, those with variant histology had a statistically worse survival (P = .03).

CONCLUSION

For patients with variant histology, delays in surgery were associated with an increased risk of death.

摘要

目的

确定浸润性膀胱癌的非典型组织学亚型根治性膀胱切除术的时机是否对生存产生影响。与单纯尿路上皮癌相比,非典型组织学具有异常行为,然而,目前尚未研究这些患者的手术时机。

材料和方法

我们从 2003 年至 2014 年共确定了 363 例接受根治性膀胱切除术且未行围手术期膀胱内和/或全身治疗的 cT2-T4N0M0 尿路上皮癌患者。对单纯尿路上皮癌和非典型组织学患者的临床病理数据进行比较。从诊断到根治性膀胱切除术的时间作为连续变量进行分析,并在 4、8 和 12 周时进行二分,以确定对肿瘤学结果的影响。

结果

与单纯尿路上皮癌患者相比,具有非典型组织学的患者更有可能出现膀胱外疾病(P<.01)、分期更高(P<.01)、有脉管侵犯(P<.01)且在根治性膀胱切除术中存在淋巴结转移(P=0.02)。单纯尿路上皮癌和非典型组织学之间,根治性膀胱切除术的中位时间无差异。在多变量分析中,控制年龄、合并症、肿瘤分期、淋巴结状态、脉管侵犯和手术切缘后,每延迟一个月,非典型组织学的总生存率越差(HR=1.36,P=0.003)。在 8 周或更长时间的延迟后,非典型组织学患者的生存状况统计学上更差(P=0.03)。

结论

对于具有非典型组织学的患者,手术延迟与死亡风险增加相关。

相似文献

1
Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer.评估膀胱癌变异组织学行膀胱切除术时间的影响。
Urology. 2019 Nov;133:157-163. doi: 10.1016/j.urology.2019.07.034. Epub 2019 Aug 14.
2
The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.浆细胞样变异型组织学对根治性膀胱切除术后膀胱癌患者生存的影响。
Eur Urol Focus. 2019 Jan;5(1):104-108. doi: 10.1016/j.euf.2017.06.013. Epub 2017 Jun 27.
3
Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?辅助化疗对根治性膀胱切除术治疗肌层浸润性膀胱癌伴不良特征和变异组织学患者的影响:组织学亚型重要吗?
Cancer. 2019 May 1;125(9):1449-1458. doi: 10.1002/cncr.31952. Epub 2019 Jan 8.
4
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.根治性膀胱切除术治疗膀胱癌患者的组织学亚型对肿瘤学结局的影响。
Eur J Cancer. 2013 May;49(8):1889-97. doi: 10.1016/j.ejca.2013.02.001. Epub 2013 Mar 4.
5
The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre.开放根治性膀胱切除术治疗肌层浸润性尿路上皮膀胱癌的组织学变异对结局的影响:来自单一三级转诊中心的结果。
World J Urol. 2021 Jun;39(6):1917-1926. doi: 10.1007/s00345-020-03364-z. Epub 2020 Jul 21.
6
The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.鳞状和腺体分化对膀胱癌根治性膀胱切除术后生存的影响。
J Urol. 2012 Aug;188(2):405-9. doi: 10.1016/j.juro.2012.04.020. Epub 2012 Jun 14.
7
Sociodemographic and survival disparities for histologic variants of bladder cancer.膀胱癌组织学亚型的社会人口统计学差异与生存差异
Can J Urol. 2018 Feb;25(1):9179-9185.
8
Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis.巢式尿路上皮癌行根治性膀胱切除术的结局:匹配队列分析。
J Urol. 2013 May;189(5):1670-5. doi: 10.1016/j.juro.2012.11.006. Epub 2012 Nov 6.
9
Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.接受根治性膀胱切除术的膀胱癌患者出现尿路上皮复发后的结局。
Urology. 2014 Dec;84(6):1420-6. doi: 10.1016/j.urology.2014.05.080. Epub 2014 Oct 11.
10
Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.膀胱癌根治性膀胱切除术后软组织切缘阳性与癌症特异性生存
J Urol. 2007 Dec;178(6):2308-12; discussion 2313. doi: 10.1016/j.juro.2007.08.023. Epub 2007 Oct 22.

引用本文的文献

1
A Retrospective Analysis of the Challenges of Urothelial Cancer Management during the COVID-19 Pandemic at a Single Academic Center in Romania.罗马尼亚某单一学术中心对COVID-19大流行期间尿路上皮癌管理挑战的回顾性分析。
Healthcare (Basel). 2023 Mar 9;11(6):812. doi: 10.3390/healthcare11060812.
2
A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyond.关于膀胱癌和上尿路尿路上皮癌手术延迟的系统评价和荟萃分析:对 COVID-19 大流行及以后的启示。
Front Surg. 2022 Oct 4;9:879774. doi: 10.3389/fsurg.2022.879774. eCollection 2022.
3
Urothelial carcinoma in COVID-19: lessons from a pandemic and their impact on clinical practice.
COVID-19 相关的尿路上皮癌:大流行中的经验教训及其对临床实践的影响。
Future Oncol. 2021 Nov;17(32):4233-4235. doi: 10.2217/fon-2021-0895. Epub 2021 Oct 21.
4
Bladder Cancer at the time of COVID-19 Outbreak.COVID-19 疫情期间的膀胱癌。
Int Braz J Urol. 2020 Jul;46(suppl.1):62-68. doi: 10.1590/S1677-5538.IBJU.2020.S107.
5
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic.COVID-19 大流行期间延迟泌尿生殖系统癌症治疗的风险:一项协作综述以帮助分诊和管理。
Eur Urol. 2020 Jul;78(1):29-42. doi: 10.1016/j.eururo.2020.04.063. Epub 2020 May 3.
6
MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer.可预测膀胱癌侵袭性的微小RNA
Cancers (Basel). 2019 Oct 14;11(10):1551. doi: 10.3390/cancers11101551.